Table 4 Treatment regimen for patients with unfavorable subsets according to STN
STN | ≤ 45.0 U/ml (n = 46) | > 45.0 U/ml (n = 26) | Total (n = 72) | p |
|---|---|---|---|---|
Lung, n (%) | 15 (33) | 4 (15) | 19 (26) | 0.16 |
Ovarian/Peritoneal, n (%) | 9 (20) | 9 (35) | 18 (25) | 0.17 |
CUP, n (%) | 5 (11) | 5 (19) | 10 (14) | 0.48 |
Breast, n (%) | 5 (11) | 1 (4) | 6 (8) | 0.41 |
Colorectal, n (%) | 2 (4) | 3 (12) | 5 (7) | 0.34 |
Ureteral/Kidney, n (%) | 3 (7) | 1 (4) | 4 (6) | 1.0 |
Biliary tract, n (%) | 2 (4) | 1 (4) | 3 (4) | 1.0 |
Salivary gland, n (%) | 1 (2) | 2 (8) | 3 (4) | 0.29 |
Cervical, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |
Nasopharyngeal, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |
Esophageal, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |
Skin, n (%) | 1 (2) | 0 | 1 (1) | 1.0 |